TY - JOUR
T1 - Gynaecological cancers in pregnancy
AU - Morice, Philippe
AU - Uzan, Catherine
AU - Gouy, Sebastien
AU - Verschraegen, Claire
AU - Haie-Meder, Christine
PY - 2012/1/1
Y1 - 2012/1/1
N2 - Cervical and ovarian cancers are the most common gynaecological cancers diagnosed during pregnancy. In early-stage cervical cancer during the first and at the beginning of the second trimester, the two main considerations for management of the patient are the tumour size (and stage) and nodal staging. MRI and laparoscopic lymphadenectomy are useful for clinicians planning a potentially conservative approach. The management of patients with locally advanced cervical disease is controversial and should be discussed on a case-by-case basis according to the tumour size, radiological findings, the term of pregnancy, and the patient's wishes. Different histological types of malignant ovarian diseases arise during pregnancy and their management depends on the diagnosis (histological subtypes, tumour differentiation, and nodal status), the tumour stage, and the trimester of the pregnancy. In patients with peritoneal spread or high-risk early-stage disease, neoadjuvant chemotherapy with pregnancy preservation could be appropriate.
AB - Cervical and ovarian cancers are the most common gynaecological cancers diagnosed during pregnancy. In early-stage cervical cancer during the first and at the beginning of the second trimester, the two main considerations for management of the patient are the tumour size (and stage) and nodal staging. MRI and laparoscopic lymphadenectomy are useful for clinicians planning a potentially conservative approach. The management of patients with locally advanced cervical disease is controversial and should be discussed on a case-by-case basis according to the tumour size, radiological findings, the term of pregnancy, and the patient's wishes. Different histological types of malignant ovarian diseases arise during pregnancy and their management depends on the diagnosis (histological subtypes, tumour differentiation, and nodal status), the tumour stage, and the trimester of the pregnancy. In patients with peritoneal spread or high-risk early-stage disease, neoadjuvant chemotherapy with pregnancy preservation could be appropriate.
UR - http://www.scopus.com/inward/record.url?scp=84856930746&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(11)60829-5
DO - 10.1016/S0140-6736(11)60829-5
M3 - Review article
C2 - 22325661
AN - SCOPUS:84856930746
SN - 0140-6736
VL - 379
SP - 558
EP - 569
JO - The Lancet
JF - The Lancet
IS - 9815
ER -